Clinical Trials Logo

Clinical Trial Summary

The main objective is to determine the contribution of a clinical pathway to improve the effectiveness of medico-surgical management of hip prosthesis infections in terms of clinical cure. The hypothesis raised is that the implementation of a clinical pathway would improve the performance of the medical and surgical management of chronic infections of prosthetic hip.


Clinical Trial Description

The incidence of surgical site infections following the orthopedic surgery is about 1%. The number of prosthesis infections is estimated between 2000 and 2500 new cases a year in France. Multiple medical and surgical care strategies are possible depending on the acute or chronic presentation, early or delayed antibiotic therapy; antibiotic therapy alone or associated with joint lavage, or with a prosthesis change in one or in two stages; after a long or short period of time, with or without fitting spacer. The practices are very heterogeneous for chronic infections depending on the terrain on which infection occurs and modalities of antibiotic therapy remain controversial. The treatment failure rate at 1 year is estimated at 20%. The hypothesis raised is that the implementation of a clinical pathway would improve the performance of the medical and surgical management of chronic infections of prosthetic hip. Objectives: To determine the contribution of a clinical pathway to improve the effectiveness of medico-surgical management of hip prosthesis infections in terms of clinical cure. The secondary objectives are: To evaluate medical and surgical practices in diagnosis and treatment of hip prosthesis infections; identify the success factors and therapeutic failure of medical and surgical supported hip prosthesis infections in terms of clinical cure; determining management of quality indicators. Methods: The clinical path will be developed by a committee of experts from the national and international recommendations, a review of the literature focused on the prosthesis conservation strategies and audit practices at the University Hospital of Grenoble. The clinical path will be evaluated by an interventional trial clustered with control group, randomized, stepped wedge (inclusion staggered in time in 4 X 3 months) with an evaluation at one year. The study population will include all patients treated for hip prosthesis infection in hospitals participating in the Alps, in a period of 16 months. The primary endpoint will be the clinical cure at one year, defined as the absence of clinical signs of infection, inflammatory syndrome (C-Reactive Protein <10 mg / L), and radiological signs of infection. Analysis: The association between the primary endpoint and the introduction of a clinical path will be quantified by the odds ratio estimated using a logistic regression model with adjustment for baseline characteristics of patients and inclusion of non-independence of observations. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02660268
Study type Interventional
Source University Hospital, Grenoble
Contact
Status Completed
Phase N/A
Start date March 21, 2016
Completion date February 7, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04251377 - Single-stage Surgery With Antibiotic-loaded Hydrogel Coated Implants Versus Two Stage Surgery for Secondary Prevention of Complex Chronic Periprosthetic Hip Joint Infection N/A
Recruiting NCT03389646 - CERAMENTTM|G and V in the Management of Hip and Knee Arthroplasty Revisions (Revision Arthroplasty Italy) Phase 4
Recruiting NCT04119804 - Early Discrimination of Periprosthetic Hip Infections Using Neural Networks (SEPTIC-ANNR)
Terminated NCT05615701 - Image Quality of EOSedge for Radiographic Evaluation of Hip Implant N/A
Recruiting NCT04304885 - Effect of Sonication on Periprosthetic Joint Infection Treatment Strategy.
Recruiting NCT05000723 - Long Term Follow-up of Patients With Prosthetic Joint Infection of the Hip Treated at University Hospitals Leuven
Completed NCT05932823 - Does the Type of Ventilation Affect the Risk for Infections After Hip Replacements?
Completed NCT01963520 - Prosthetic Hip Infections: Prospective Study N/A
Recruiting NCT04488458 - Susceptibility Testing of Biofilm to Guide Treatment of Periprosthetic Joint Infections N/A
Completed NCT03161990 - DAIR for Infected Total Hip Arthroplasty - Does the Operative Approach Influence the Functional Result?